Neuropsychological and depression measures have been found to predict cognitive functioning. We compared these associations among whites and Spanish-speaking Hispanics.
Methods:
Fifty-two pairs of whites and Hispanics were matched demographically and clinically in a cross-sectional study. Hierarchical regression analyses predicted Global Deterioration Scale (GDS) rating by baseline neuropsychological tests and depression symptoms.
Results:
Neuropsychological tests predicted GDS better in whites; depression symptoms—specifically retardation—predicted well in Hispanics but not whites. Immediate recall of the New York University (NYU)-Paragraph Test and the Retardation item of the Hamilton Depression Rating Scale were associated with GDS in Hispanics and delayed recall of the NYU-Paragraph Test and Wechsler Adult Intelligence Scale-Digit Symbol in whites. Neuropsychological tests and depression symptoms predicted GDS differently in Hispanics and whites.
Discussion:
These results suggest that other measures should be considered to increase the predictive accuracy of neuropsychological tests when assessing cognitive status in Spanish-speaking Hispanics. Additional studies of specific ethnic/racial and sociodemographic subgroups are warranted.
2010 Alzheimer’s disease facts and figures. Alzheimers Dement. 2010;6(2):158–194.
3.
GurlandBJWilderDELantiguaR. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry. 1999;14(6):481–493.
4.
TangMXCrossPAndrewsH. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56(1):49–56.
5.
FittenLJOrtizFPontonM. Frequency of Alzheimer’s disease and other dementias in a community outreach sample of Hispanics. J Am Geriatr Soc. 2001;49(10):1301–1308.
6.
BorsonSScanlanJMWatanabeJTuSPLessigM. Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry. 2006;21(4):349–355.
7.
NordlundARolstadSHellstromPSjogrenMHansenSWallinA. The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry. 2005;76(11):1485–1490.
8.
SalmonDPThomasRGPayMM. Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals. Neurology. 2002;59(7):1022–1028.
9.
ChodoshJReubenDBAlbertMSSeemanTE. Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur studies of successful aging. J Am Geriatr Soc. 2002;50(6):1051–1060.
10.
FlickerCFerrisSHReisbergB. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41(7):1006–1009.
11.
KlugerAFerrisSHGolombJMittelmanMSReisbergB. Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol. 1999;12(4):168–179.
12.
LangeKLBondiMWSalmonDP. Decline in verbal memory during preclinical Alzheimer’s disease: examination of the effect of APOE genotype. J Int Neuropsychol Soc. 2002;8(7):943–955.
13.
ByrdDATouradjiPTangMXManlyJJ. Cancellation test performance in African American, Hispanic, and White elderly. J Int Neuropsychol Soc. 2004;10(3):401–411.
14.
CoffeyDMMarmolLSchockLAdamsW. The influence of acculturation on the Wisconsin card sorting test by Mexican Americans. Arch Clin Neuropsychol. 2005;20(6):795–803.
15.
JacobsDMSanoMAlbertSSchofieldPDooneiefGSternY. Cross-cultural neuropsychological assessment: a comparison of randomly selected, demographically matched cohorts of English- and Spanish-speaking older adults. J Clin Exp Neuropsychol. 1997;19(3):331–339.
16.
LoewensteinDAArguellesTBarkerWWDuaraR. A comparative analysis of neuropsychological test performance of Spanish-speaking and English-speaking patients with Alzheimer’s disease. J Gerontol. 1993;48(3):P142–P149.
17.
LezakMD. Neuropsychological Assessment. New York: Oxford University; 1995.
18.
FoldiNSLoboscoJJSchaeferLA. The effect of attentional dysfunction in Alzheimer’s disease: theoretical and practical implications. Semin Speech Lang. 2002;23(2):139–150.
19.
KlugerAGianutsosJGGolombJ. Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci. 1997;52(1):P28–P39.
20.
BergLDanzigerWLStorandtM. Predictive features in mild senile dementia of the Alzheimer type. Neurology. 1984;34(5):563–569.
21.
MasurDMSliwinskiMLiptonRBBlauADCrystalHA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology. 1994;44(8):1427–1432.
22.
AlexopoulosGSBuckwalterKOlinJMartinezRWainscottCKrishnanKR. Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. Biol Psychiatry. 2002;52(6):543–558.
23.
ReisbergBFranssenESclanSGKlugerAFerrisSH. Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer’s disease: a study of 120 patients using the BEHAVE-AD. Bull Clin Neurosci. 1989;54:95–112.
24.
RappMASchnaider-BeeriMGrossmanHT. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry. 2006;63(2):161–167.
25.
LyketsosCGLopezOJonesBFitzpatrickALBreitnerJDeKoskyS. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288(12):1475–1483.
26.
StarksteinSEJorgeRMizrahiRRobinsonRG. A prospective longitudinal study of apathy in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2006;77(1):8–11.
27.
DevanandDPSanoMTangMX. Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry. 1996;53(2):175–182.
28.
PaternitiSVerdier-TailleferMHDufouilCAlperovitchA. Depressive symptoms and cognitive decline in elderly people. Longitudinal study. Br J Psychiatry. 2002;181:406–410.
29.
WilsonRSBarnesLLMendes de LeonCF. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59(3):364–370.
30.
WilsonRSMendes De LeonCFBennettDABieniasJLEvansDA. Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry. 2004;75(1):126–129.
31.
ReisbergBShulmanMBTorossianCLengLZhuW. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement. 2010;6(1):11–24.
32.
HamiltonM. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
33.
BergerAKFratiglioniLForsellYWinbladBBäckmanL. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology. 1999;53(9):1998–2002.
34.
DufouilCFuhrerRDartiguesJFAlperovitchA. Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol. 1996;144(7):634–641.
35.
CervillaJAPrinceMJoelsSMannA. Does depression predict cognitive outcome 9 to 12 years later? Evidence from a prospective study of elderly hypertensives. Psychol Med. 2000;30(5):1017–1023.
36.
GeerlingsMISchmandBBraamAWJonkerCBouterLMvan TilburgW. Depressive symptoms and risk of Alzheimer’s disease in more highly educated older people. J Am Geriatr Soc. 2000;48(9):1092–1097.
37.
van ReekumRSimardMClarkeDBinnsMAConnD. Late-life depression as a possible predictor of dementia: cross-sectional and short-term follow-up results. Am J Geriatr Psychiatry. 1999;7(2):151–159.
38.
AlexopoulosGSMeyersBSYoungRCMattisSKakumaT. The course of geriatric depression with “reversible dementia”: a controlled study. Am J Psychiatry. 1993;150(11):1693–1699.
39.
FolsteinMFFolsteinSEMcHughPR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
40.
RajiMAReyes-OrtizCAKuoYFMarkidesKSOttenbacherKJ. Depressive symptoms and cognitive change in older Mexican Americans. J Geriatr Psychiatry Neurol. 2007;20(3):145–152.
41.
PerrinoTMasonCABrownSCSpokaneASzapocznikJ. Longitudinal relationships between cognitive functioning and depressive symptoms among Hispanic older adults. J Gerontol B Psychol Sci Soc Sci. 2008;63(5):P309–P317.
42.
Association AP. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA; 1994.
43.
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology. 1984;34(7):939–944.
44.
ReisbergB. Global Deterioration Scale (GDS). Psychopharmacol Bull. 1988;24(4):661–663.
45.
De SantiSPirragliaEBarrW. Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology. 2008;22(4):469–484.
46.
ReisbergBFerrisSHDe LeonMJ. Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type. Drug Dev Res. 1988;15(2-3):101–114.
47.
ReisbergBFerrisSHDe LeonMJCrookT. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–1139.
48.
CatalanoFL. A preliminary report on a new memory scale. Percept Mot Skills. 1968;27(1):277–278.
49.
CrookTGilbertJGFerrisS. Operationalizing memory impairment for elderly persons: the Guild memory test. Psychol Rep. 1980;47(3 pt 2):1315–1318.
50.
WechslerD. Wechsler Adult Intelligence Scale. New York, NY: Psychological Corporation; 1955.
51.
FerrisSCrookTFlickerC. Asessing cognitive impairment and evaluating treatment effects: psychometric performance tests. In: PoonLW, ed. Clinical Memory Assessment of Older Patients. Washington, DC: American Psychological Association; 1986.
52.
EdicionesT. WAIS-III Escala de Inteligencia de Wechsler para Adultos-III: Manual Technico. Madrid, Espana: TEA Ediciones; 2001.
53.
RenteriaLLiSTPliskinNH. Reliability and validity of the Spanish Language Wechsler Adult Intelligence Scale (3 rd Edition) in a sample of American, urban, Spanish-speaking Hispanics. Clin Neuropsychol. 2008;22(3):455–470.
54.
WechslerD. Manual para la Escala de Inteligencia Wechsler para Adultos. New York, NY: Psychological Corporation; 1968.
55.
KatzIR. Diagnosis and treatment of depression in patients with Alzheimer’s disease and other dementias. J Clin Psychiatry. 1998;59(suppl 9):38–44.
56.
Lewis-FernandezRBlancoCMallinckrodtCHWohlreichMMWatkinJGPlewesJM. Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patients. J Clin Psychiatry. 2006;67(9):1379–1390.
57.
WilliamsJWJrKerberCAMulrowCDMedinaAAguilarC. Depressive disorders in primary care: prevalence, functional disability, and identification. J Gen Intern Med. 1995;10(1):7–12.
58.
HolmS. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65–70.
59.
FalconLMTuckerKL. Prevalence and correlates of depressive symptoms among Hispanic elders in Massachusetts. J Gerontol B Psychol Sci Soc Sci. 2000;55(2):S108–S116.
60.
JonssonMEdmanALindKRolstadSSjogrenMWallinA. Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia. Int J Geriatr Psychiatry. 2010;25(6):588–595.
61.
AlexopoulosGS. Role of executive function in late-life depression. J Clin Psychiatry. 2003;64(suppl 14):18–23.
62.
LavretskyHZhengLWeinerMW. The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry. 2008;23(10):1040–1050.
63.
ManlyJJ. Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol. 2004;11(1):37–46.
64.
CosentinoS. Do reading tests measure the same construct in multiethnic and multilingual older persons?J Int Neuropsychol Soc. 2007;13(2):228–236.
